ArticleOncology research2026

Isoliquiritigenin Impedes Breast Cancer Progression through PITX1-PFKP-Mediated Glycolysis Reprogramming.

Cong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.